Aardvark Therapeutics Competitors and Similar CompaniesClear all
Aardvark Therapeutics's competitors and similar companies include AptamiR Therapeutics, Livzon Pharmaceutical Group, UCB and Genentech.
 Aardvark Therapeutics Aardvark Therapeutics is a company that specializes in small molecule therapeutics for obesity and rare genetic metabolic disorders. |  AptamiR Therapeutics AptamiR Therapeutics is a biotechnology company focused on developing a treatment for human obesity and related cardiometabolic disorders. |  Livzon Pharmaceutical Group Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products. |  UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions. |  Genentech Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines. | |
Founding Date | Founding Date 2017 | Founding Date 2012 | Founding Date 1985 | Founding Date 1928 | Founding Date 1976 |
Type | Type Public | Type Private | Type Public | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations San Diego, US HQ San Diego, US | Locations Austin, US HQ | Locations Zhuhai, CN HQ Chengdu, CN Qingyuan, CN Shanghai, CN Shaoguan, CN Shenzhen, CN Zhuhai, CN | Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more | Locations South San Francisco, US HQ Hillsboro, US Oceanside, US Portland, US South San Francisco, US South San Francisco, US South San Francisco, US see more |
Employees | Employees 18 | Employees N/A | Employees 9,067 | Employees 9,052 | Employees 18,077 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 4.2 b | Valuation ($) 34.3 b | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) ¥11.7b (FY, 2025) | Revenue (est.) €7.4b (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods ¥4.1b (FY, 2025) | Cost of goods €1.4b (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit ¥7.8b (FY, 2025) | Gross profit €7.2b (FY, 2025) | Gross profit N/A |
Net income | Net income ($57.6m) (FY, 2025) | Net income N/A | Net income ¥2.4b (FY, 2025) | Net income €1.6b (FY, 2025) | Net income N/A |
For sources of this data, please see the company profile
View Company Profiles
AptamiR Therapeutics
HQ
Austin, US
AptamiR Therapeutics is a biotechnology company focused on developing a treatment for human obesity and related cardiometabolic disorders.
View companyLivzon Pharmaceutical Group
HQ
Zhuhai, CN
Employees
9,067
Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products.
View companyUCB
HQ
Brussels, BE
Employees
9,052
UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
View companyGenentech
HQ
South San Francisco, US
Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines.
View company